Be Careful Of Fecal Transplants, Warns FDA, After Patient Death
The FDA has strengthened oversight of experimental fecal transplants after a patient died of an infection. The donor's stool contained disease-causing pathogens, but was not tested before use.
Two people got very sick, and one died, during a trial of an experimental procedure known as fecal transplant, according to a statement issued Thursday from the Food and Drug Administration. As a result, the agency is suspending several clinical trials investigating the procedure until safety standards can be assured.
Researchers are infection, which led to in 2015. FMT, which involves transplanting stool from a healthy person into the colon of a sick person, is still not approved by the FDA.
